LRRK2-IN-2 (化合物 22) 是一种有效，选择性，具有口服活性和可透过血脑屏障的LRRK2抑制剂，IC50值为 0.6 nM。LRRK2-IN-2 可用于帕金森氏病的研究。

LRRK2-IN-2 (compoubd 22) is a potent, selective, orally active and brain-penetrant inhibitor LRRK2, with IC 50 of<0.6 nM. LRRK2-IN-2 can be used for the research of Parkinson's disease [1].

2641059-19-8

C23H23Cl2F3N6O2

543.37

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years